// App-Quantinova.ai

GS2-04 : Improvements in long-term outcome for women with estrogen receptor positive (ER+) early stage breast cancer treated with 5 years of endocrine therapy: Analyses of 82,598 women in the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) database

Researchers

Presenter

  • Hongchao Pan

Principal Investigators

  • Jeremy Braybrooke

  • Richard Gray

  • Richard Peto

  • Rosie Bradley

  • Robert Hills

  • Jonas Bergh

  • Sandra M Swain

  • Mitchell Dowsett

  • Daniel F Hayes

  • Richard D Gelber

Medical Centers

  • Nuffield Department of Population Health HSRU, University of Oxford, Oxford, United Kingdom

  • Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Centre, Cancer theme, Karolinska University Hospital, Solna, Sweden

  • Georgetown University Medical Center, Washington, DC

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Locations

  • United Kingdom

  • Sweden

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved